Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Thu Apr 15 CET - Fri Apr 16 CET (over 3 years ago)
In your timezone (EST): Thu Apr 15 8:30am - Fri Apr 16 1:20pm |
Location | Online Event |
Region | EMEA |
Advancing qPCR and dPCR technological developments and its applications in oncology and infectious disease diagnostics
As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.
MarketsandMarkets are proud to host its inaugural “qPCR and dPCR Virtual Conference”. The conference will focus on the latest developments in digital and real time PCR and also, it’s application in cancer diagnosis and infectious disease diagnostics.
2021 Speakers
David Zarling
CEO, Colby Pharmaceuticals, USA
Loo Keat Wei
Assistant Professor, Faculty of Science, Universiti Tunku Abdul Rahman (UTAR), Malaysia
Antoinette Perry
Lecturer, Cancer Biology, University College Dublin, Ireland
Laxmi Silwal-Pandit
Department of Cancer Genetics, Oslo University Hospital, Norway
Valerie Taly
Research Director, CNRS, INSERM, France
Andreas Weinhaeusel
Thematic Coordinator, Molecular Diagnostics, AIT Austrian Institute of Technology, Austria
Pawel Debski
Senior Analyst, Scope Fluidics, Poland
2021 Partners
MEDIA PARTNERS:
• PharmaVOICE
• PharmaTutor
• Pharma Journalist